Compare Johnson Controls International PLC (JCI) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? Johnson Controls International PLC trades at $151.51 (market cap $92.34B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.89B). The key difference: Johnson Controls International PLC is the larger of the two by market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| JCI | RELX | |
|---|---|---|
Market Cap | $92.34B | $63.89B |
Volume | 5,497,477 | 2,760,502 |
Sector | Basic Materials | Industrials |
52-Week High | $158.76 | $46.80 |
52-Week Low | $108.54 | $27.73 |
Typical Hold Time | 66 Days | — |
Enterprise Value | $101.17B | $75.40B |
Dividend Yield | 1.05% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson Controls International (JCI) trades at $156.47, up 0.68% today, with a bullish technical outlook and strong institutional support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.58. Revenue for 2025 was $23.60B, with net income surging to $3.29B, reflecting a robust profit margin of 13.94%. Recent news highlights strong Q3 2026 results and raised full-year guidance, driven by demand in data-center thermal management systems.
JCI presents a favorable investment case with solid fundamentals, analyst consensus pointing to a $172.50 price target, and no sell ratings among 45 analysts. Key risks include rising debt-to-asset ratios and macroeconomic sensitivity. The stock's valuation multiples are elevated, but growth in high-margin segments supports upside potential. Institutional ownership trends show increased positions, reinforcing confidence in the company's strategic direction.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
